Spots Global Cancer Trial Database for Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
Official Title: A Prospective, Multicenter, Non-interventional Study to Evaluate Quality of Life in Chinese Postmenopausal HR(+) EBC Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
Study ID: NCT01144572
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to evaluate quality of life (Qol) in postmenopausal HR (+) EBC patients during adjuvant AIs treatment in terms of: the change of the trial outcome index (TOI) of the FACT-B questionnaire from baseline to 24 months. This study will recruit approximately 500 patients from 21 sites in China. The patients should be postmenopausal HR (+) EBC patients who have already start adjuvant AIs treatment but within 7 days.
Detailed Description:
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Beijing, Beijing, China
Research Site, Guangzhou, Guangdong, China
Research Site, Shenzhen, Guangdong, China
Research Site, Guiyang, Guizhou, China
Research Site, Harbin, Heilongjiang, China
Research Site, Changsha, Hunan, China
Research Site, Nanjing, Jiangsu, China
Research Site, Changchun, Jilin, China
Research Site, Shanghai, Shanghai, China
Research Site, Xi'an, Shanxi, China
Research Site, Tianjin, Tianjin, China
Research Site, Kunming, Yunnan, China
Research Site, Hangzhou, Zhejiang, China
Research Site, Ningbo, Zhejiang, China
Research Site, Wenzhou, Zhejiang, China
Contact Details
Name: Prof. Shao Zhimin
Affiliation: Fudan University
Role: PRINCIPAL_INVESTIGATOR
Name: Karen Atkin
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Name: Xu Johnson
Affiliation: AstraZeneca
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
